Add to ORKGA phase II trial of Xeloda and oxaliplatin (XELOX) neo‑adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para‑aortic lymph node metastasi
Dept. of Medicine/석사Purpose: This randomized phase II trial evaluated two oxaliplatin-based regimens...
Abstract Objectives Exploring the efficacy and safety of perioperative chemotherapy on patients with...
Aims and background: Previous phase II studies have reported that combinations of oxaliplatin, folin...
This letter to editor is a comment to the paper by Wang et al. entitled: "A phase II trial of Xeloda...
Objective: The prognosis of patients with advanced gastric cancer (GC) with multiple lymph-node meta...
To compare capecitabine and oxaliplatin (XELOX) with S-1 as adjuvant chemotherapy in stage III gastr...
Background: We modified 3-week XELOX regimen with oxaliplatin to 85 mg/m 2 on Day 1 and capecitabine...
[[abstract]]Background: Fluorouracil and platinum can be considered a standard option for advanced g...
AIM: To compare capecitabine and oxaliplatin (XELOX) with S-1 as adjuvant chemotherapy in stage III ...
Background:The ACTS-GC study had shown postoperative adjuvant therapy with S-1 improved survival of ...
Abstract Background S-1 plus oxaliplatin(SOX) has been demonstrated to be effective and well tolerat...
doi:10.1093/annonc/mdq065original article A phase II study of bevacizumab, oxaliplatin, and docetaxe...
[[abstract]]Background: Fluorouracil and platinum can be considered a standard option for advanced g...
Gastric cancer is a common malignancy worldwide with a high mortality rate. In advanced gastric canc...
Abstract Background Large type 3 and type 4 gastric cancers have extremely poor prognoses. To addres...
Dept. of Medicine/석사Purpose: This randomized phase II trial evaluated two oxaliplatin-based regimens...
Abstract Objectives Exploring the efficacy and safety of perioperative chemotherapy on patients with...
Aims and background: Previous phase II studies have reported that combinations of oxaliplatin, folin...
This letter to editor is a comment to the paper by Wang et al. entitled: "A phase II trial of Xeloda...
Objective: The prognosis of patients with advanced gastric cancer (GC) with multiple lymph-node meta...
To compare capecitabine and oxaliplatin (XELOX) with S-1 as adjuvant chemotherapy in stage III gastr...
Background: We modified 3-week XELOX regimen with oxaliplatin to 85 mg/m 2 on Day 1 and capecitabine...
[[abstract]]Background: Fluorouracil and platinum can be considered a standard option for advanced g...
AIM: To compare capecitabine and oxaliplatin (XELOX) with S-1 as adjuvant chemotherapy in stage III ...
Background:The ACTS-GC study had shown postoperative adjuvant therapy with S-1 improved survival of ...
Abstract Background S-1 plus oxaliplatin(SOX) has been demonstrated to be effective and well tolerat...
doi:10.1093/annonc/mdq065original article A phase II study of bevacizumab, oxaliplatin, and docetaxe...
[[abstract]]Background: Fluorouracil and platinum can be considered a standard option for advanced g...
Gastric cancer is a common malignancy worldwide with a high mortality rate. In advanced gastric canc...
Abstract Background Large type 3 and type 4 gastric cancers have extremely poor prognoses. To addres...
Dept. of Medicine/석사Purpose: This randomized phase II trial evaluated two oxaliplatin-based regimens...
Abstract Objectives Exploring the efficacy and safety of perioperative chemotherapy on patients with...
Aims and background: Previous phase II studies have reported that combinations of oxaliplatin, folin...